BrightPath-Cellistic partner for clinical trial advancements of CAR-T cell therapy Yahoo Finance
BrightPath-Cellistic partner for clinical trial advancements of CAR-T cell therapy Yahoo Finance
Restoring Vision: The Promise of Stem Cells in Healing Blindness This is Local London
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell BioSpace
Abstract Induced pluripotent stem cells (iPSCs) are a new type of pluripotent cells that can be obtained by reprogramming animal and human differentiated cells. In this review, issues related to the nature of iPSCs are discussed and different methods of iPSC production are described. We particularly focused on methods of iPSC production without the genetic modification of the cell genome and with means for increasing the iPSC production efficiency. The possibility and issues related to the safety of iPSC use in cell replacement therapy of human diseases and a study of new medicines are considered
Induced pluripotent stem cell technology is a powerful tool that scientists at the Institute for Stem Cell and Regenerative Medicine use to study a wide range of diseases. To understand the usefulness of induced pluripotent stem cells, it helps to know a few basic facts about stem cells and the role they play in research. There are many types of stem cells. In general, the term stem cell refers to a category of cells that give rise to other cells (like skin, blood, heart, and muscle cells) by replicating and differentiating in response to chemical cues
Abstract Induced pluripotent stem cells (iPSC) technology has propelled the field of stem cells biology, providing new cells to explore the molecular mechanisms of pluripotency, cancer biology and aging. A major advantage of human iPSC, compared to the pluripotent embryonic stem cells, is that they can be generated from virtually any embryonic or adult somatic cell type without destruction of human blastocysts
Induced pluripotent stem cells (iPSC) are artificially derived from adult stem cells by manipulating gene expression. This avoids using embryos a method thats garnered a lot of controversy as is done with embryonic stem cells.
Generation and long-term culture of human cerebellar organoids from pluripotent stem cells Nature.com
Whats the secret to living to 100? Centenarian stem cells could offer clues Nature.com
Single-cell RNA sequencing reveals key regulators and differentiation trajectory of iPSC-derived cardiomyocytes Nature.com
Recent Comments